{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:41:07Z","timestamp":1785451267994,"version":"3.56.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neovascular age-related macular degeneration (nAMD) is a complex and multi-factorial disease, and low-grade inflammation is associated with pathogenesis of nAMD. Aqueous humor could reflect intraocular immune environments in various eye diseases. The research so far used aqueous humor samples and revealed that inflammation is involved in pathophysiology of nAMD, although immunological roles of cytokines were evaluated inadequately with aspect to individual effects. Here we used 27 kinds of cytokines covering general immunologic reactions, examined specific expression patterns of cytokines, and assessed relationships between inflammation and pathophysiology of nAMD by multivariate analyses. In nAMD eyes, principal component analysis showed that IL-7, MCP-1, MIP-1\u03b2 and VEGF had high principal component loadings of over 0.6 in the first principal component constituting 32.6% of all variability of the data. In exploratory factor analysis, IL-6, MCP-1 and MIP-1\u03b2 had high factor loadings (FL) of over 0.5 in Factor 1 constituting 32.6% of all variability, while VEGF had FL of over 1.0 in Factor 3 constituting 10.7% of all variability. In hierarchical cluster analysis, MCP-1 and VEGF were located in the cluster of first proximate mutual distance to central retinal thickness. These data could suggest that low-grade inflammation is a principal contributor in nAMD.<\/jats:p>","DOI":"10.1038\/s41598-019-55191-x","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T11:02:52Z","timestamp":1576753372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Comprehensive expression patterns of inflammatory cytokines in aqueous humor of patients with neovascular age-related macular degeneration"],"prefix":"10.1038","volume":"9","author":[{"given":"Tomohito","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Karasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Enoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,19]]},"reference":[{"key":"55191_CR1","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1056\/NEJMra0801537","volume":"358","author":"RD Jager","year":"2008","unstructured":"Jager, R. D., Mieler, W. F. & Miller, J. W. Age-related macular degeneration. N. Engl. J. Med. 358, 2606\u20132617 (2008).","journal-title":"N. Engl. J. Med."},{"key":"55191_CR2","first-page":"417","volume":"109","author":"Japanese Study Group of Polypoidal Choroidal Vasculopathy","year":"2005","unstructured":"Japanese Study Group of Polypoidal Choroidal Vasculopathy. Criteria for diagnosis of polypoidal choroidal vasculopathy. Nippon Ganka Gakkai Zasshi 109, 417\u2013427 (2005).","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"55191_CR3","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1189\/jlb.3RI0615-239R","volume":"98","author":"M Chen","year":"2015","unstructured":"Chen, M. & Xu, H. Parainflammation, chronic inflammation, and age-related macular degeneration. J. Leukoc. Biol. 98, 713\u2013725 (2015).","journal-title":"J. Leukoc. Biol."},{"key":"55191_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/medicina46020013","volume":"46","author":"R Liutkeviciene","year":"2010","unstructured":"Liutkeviciene, R., Lesauskaite, V., Asmoniene, V., Zaliuniene, D. & Jasinskas, V. Factors determining age-related macular degeneration: a current view. Medicina (Kaunas) 46, 89\u201394 (2010).","journal-title":"Medicina (Kaunas)"},{"key":"55191_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.survophthal.2005.12.001","volume":"51","author":"LA Donoso","year":"2006","unstructured":"Donoso, L. A., Kim, D., Frost, A., Callahan, A. & Hageman, G. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 51, 137\u2013152 (2006).","journal-title":"Surv. Ophthalmol."},{"key":"55191_CR6","first-page":"32","volume":"5","author":"BS Winkler","year":"1999","unstructured":"Winkler, B. S., Boulton, M. E., Gottsch, J. D. & Sternberg, P. Oxidative damage and age-related macular degeneration. Mol. Vis. 5, 32 (1999).","journal-title":"Mol. Vis."},{"key":"55191_CR7","doi-asserted-by":"publisher","first-page":"29354","DOI":"10.1074\/jbc.M910191199","volume":"275","author":"J Liu","year":"2000","unstructured":"Liu, J., Itagaki, Y., Ben-Shabat, S., Nakanishi, K. & Sparrow, J. R. The biosynthesis of A2E, a fluorophore of aging retina, involves the formation of the precursor, A2-PE, in the photoreceptor outer segment membrane. J. Biol. Chem. 275, 29354\u201329360 (2000).","journal-title":"J. Biol. Chem."},{"key":"55191_CR8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0002-9394(02)01624-0","volume":"134","author":"DH Anderson","year":"2002","unstructured":"Anderson, D. H., Mullins, R. F., Hageman, G. S. & Johnson, L. V. A role for local inflammation in the formation of drusen in the aging eye. Am. J. Ophthalmol. 134, 411\u2013431 (2002).","journal-title":"Am. J. Ophthalmol."},{"key":"55191_CR9","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1097\/IAE.0000000000000157","volume":"34","author":"T Agawa","year":"2014","unstructured":"Agawa, T. et al. Profile of Intraocular Immune Mediators in Patients with Age-Related Macular Degeneration and the Effect of Intravitreal Bevacizumab Injection. Retina 34, 1811\u20131818 (2014).","journal-title":"Retina"},{"key":"55191_CR10","doi-asserted-by":"publisher","first-page":"5818","DOI":"10.1167\/iovs.09-3928","volume":"50","author":"R Reynolds","year":"2009","unstructured":"Reynolds, R. et al. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest. Ophthalmol. Vis. Sci. 50, 5818\u20135827 (2009).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"55191_CR11","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2174\/1566524016666160324130031","volume":"16","author":"M Chen","year":"2016","unstructured":"Chen, M. et al. STAT3 activation in circulating monocytes contributes to neovascular age-related macular degeneration. Curr. Mol. Med. 16, 412\u2013423 (2016).","journal-title":"Curr. Mol. Med."},{"key":"55191_CR12","doi-asserted-by":"publisher","first-page":"5292","DOI":"10.1167\/iovs.11-9165","volume":"53","author":"M Grunin","year":"2012","unstructured":"Grunin, M., Burstyn-Cohen, T., Hagbi-Levi, S., Peled, A. & Chowers, I. Chemokine receptor expression in peripheral blood monocytes from patients with neovascular age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 53, 5292\u20135300 (2012).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"55191_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/aos.13886","volume":"97","author":"Y Subhi","year":"2019","unstructured":"Subhi, Y. et al. Plasma markers of chronic low-grade inflammation in polypoidal choroidal vasculopathy and neovascular age-related macular degeneration. Acta Ophthalmol. (Copenh.) 97, 99\u2013106 (2019).","journal-title":"Acta Ophthalmol. (Copenh.)"},{"key":"55191_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0820-y","volume":"14","author":"J Lechner","year":"2017","unstructured":"Lechner, J. et al. Peripheral blood mononuclear cells from neovascular age-related macular degeneration patients produce higher levels of chemokines CCL2 (MCP-1) and CXCL8 (IL-8). J. Neuroinflammation. 14, 42 (2017).","journal-title":"J. Neuroinflammation."},{"key":"55191_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/srep29046","volume":"6","author":"M Grunin","year":"2016","unstructured":"Grunin, M., Rinsky, B., Smith, Y. & Chowers, I. Transcriptome analysis on monocytes from patients with neovascular age-related macular degeneration. Sci. Rep. 6, 29046 (2016).","journal-title":"Sci. Rep."},{"key":"55191_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/sj.eye.6702498","volume":"22","author":"H Noma","year":"2008","unstructured":"Noma, H. et al. Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye (Lond) 22, 42\u201348 (2008).","journal-title":"Eye (Lond)"},{"key":"55191_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00417-004-0950-7","volume":"243","author":"H Funatsu","year":"2005","unstructured":"Funatsu, H. et al. Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients. Graefes Arch Clin Exp Ophthalmol. 243, 3\u20138 (2005).","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"55191_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19594-6","volume":"8","author":"T Sato","year":"2018","unstructured":"Sato, T., Takeuchi, M., Karasawa, Y., Enoki, T. & Ito, M. Intraocular inflammatory cytokines in patients with neovascular age-related macular degeneration before and after initiation of intravitreal injection of anti-VEGF inhibitor. Sci. Rep. 8, 1098 (2018).","journal-title":"Sci. Rep."},{"key":"55191_CR19","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1001\/archophthalmol.2010.227","volume":"128","author":"JB Jonas","year":"2010","unstructured":"Jonas, J. B., Tao, Y., Neumaier, M. & Findeisen, P. Monocyte chemoattractant protein 1, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 in exudative age-related macular degeneration. Arch. Ophthalmol. 128, 1281\u20131286 (2010).","journal-title":"Arch. Ophthalmol."},{"key":"55191_CR20","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/ajcp\/105.5.589","volume":"105","author":"MC Cohen","year":"1996","unstructured":"Cohen, M. C. & Cohen, S. Cytokine function: a study in biologic diversity. Am. J. Clin. Pathol. 105, 589\u2013598 (1996).","journal-title":"Am. J. Clin. Pathol."},{"key":"55191_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","volume":"45","author":"JM Zhang","year":"2007","unstructured":"Zhang, J. M. & An, J. Cytokines, inflammation, and pain. Int. Anesthesiol. Clin. 45, 27\u201337 (2007).","journal-title":"Int. Anesthesiol. Clin."},{"key":"55191_CR22","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/S0161-6420(00)00409-7","volume":"107","author":"Age-Related Eye Disease Study Research Group","year":"2000","unstructured":"Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration: a case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology 107, 2224\u20132232 (2000).","journal-title":"Ophthalmology"},{"key":"55191_CR23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/00004397-198702740-00006","volume":"27","author":"The Early Treatment Diabetic Retinopathy Study Research Group","year":"1987","unstructured":"The Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report no. 4. Int. Ophthalmol. Clin. 27, 265\u2013272 (1987).","journal-title":"Int. Ophthalmol. Clin."},{"key":"55191_CR24","doi-asserted-by":"crossref","unstructured":"Jolliffe, I. International encyclopedia of statistical science. 1094\u20131096 (Springer, 2011).","DOI":"10.1007\/978-3-642-04898-2_455"},{"key":"55191_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s10803-009-0816-2","volume":"40","author":"M Norris","year":"2010","unstructured":"Norris, M. & Lecavalier, L. Evaluating the use of exploratory factor analysis in developmental disability psychological research. J. Autism Dev. Disord. 40, 8\u201320 (2010).","journal-title":"J. Autism Dev. Disord."},{"key":"55191_CR26","doi-asserted-by":"crossref","unstructured":"Wilks, D. S. International geophysics Vol. 100. 603\u2013616 (Elsevier, 2011).","DOI":"10.1016\/B978-0-12-385022-5.00015-4"},{"key":"55191_CR27","doi-asserted-by":"crossref","unstructured":"Eberly, L. E. Topics in Biostatistics. 165\u2013187 (Springer, 2007).","DOI":"10.1007\/978-1-59745-530-5_9"},{"key":"55191_CR28","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1016\/j.ophtha.2009.05.039","volume":"116","author":"M Funk","year":"2009","unstructured":"Funk, M. et al. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab. Ophthalmology 116, 2393\u20132399 (2009).","journal-title":"Ophthalmology"},{"key":"55191_CR29","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/IAE.0b013e318195cb15","volume":"29","author":"MI Roh","year":"2009","unstructured":"Roh, M. I. et al. Concentration of cytokines in the aqueous humor of patients with naive, recurrent and regressed CNV associated with and after bevacizumab treatment. Retina 29, 523\u2013529 (2009).","journal-title":"Retina"},{"key":"55191_CR30","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1001\/archophthalmol.2010.227","volume":"128","author":"JB Jonas","year":"2010","unstructured":"Jonas, J. B., Tao, Y., Neumaier, M. & Findeisen, P. Monocyte chemoattractant protein 1, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 in exudative age-related macular degeneration. Arch. Ophthalmol. 128, 1281\u20131286 (2010).","journal-title":"Arch. Ophthalmol."},{"key":"55191_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.molmed.2014.10.005","volume":"21","author":"A Sene","year":"2015","unstructured":"Sene, A., Chin-Yee, D. & Apte, R. S. Seeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye. Trends Mol. Med. 21, 43\u201351 (2015).","journal-title":"Trends Mol. Med."},{"key":"55191_CR32","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1161\/CIRCULATIONAHA.105.605121","volume":"113","author":"EA Heller","year":"2006","unstructured":"Heller, E. A. et al. Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells. Circulation 113, 2301\u20132312 (2006).","journal-title":"Circulation"},{"key":"55191_CR33","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1046\/j.1365-2567.1998.00643.x","volume":"95","author":"B Neumann","year":"1998","unstructured":"Neumann, B., Emmanuilidis, K., Stadler, M. & Holzmann, B. Distinct functions of interferon-gamma for chemokine expression in models of acute lung inflammation. Immunology 95, 512\u2013521 (1998).","journal-title":"Immunology"},{"key":"55191_CR34","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1167\/iovs.11-8232","volume":"53","author":"S Fujimura","year":"2012","unstructured":"Fujimura, S. et al. Angiostatic effect of CXCR3 expressed on choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 53, 1999\u20132006 (2012).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"55191_CR35","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1167\/iovs.11-9095","volume":"54","author":"T Mizutani","year":"2013","unstructured":"Mizutani, T., Ashikari, M., Tokoro, M., Nozaki, M. & Ogura, Y. Suppression of laser-induced choroidal neovascularization by a CCR3 antagonist. Invest. Ophthalmol. Vis. Sci. 54, 1564\u20131572 (2013).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"55191_CR36","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1084\/jem.182.1.155","volume":"182","author":"AL Angiolillo","year":"1995","unstructured":"Angiolillo, A. L. et al. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J. Exp. Med. 182, 155\u2013162 (1995).","journal-title":"J. Exp. Med."},{"key":"55191_CR37","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1165\/rcmb.2004-0175OC","volume":"31","author":"AM Tager","year":"2004","unstructured":"Tager, A. M. et al. Inhibition of pulmonary fibrosis by the chemokine IP-10\/CXCL10. Am. J. Respir. Cell Mol. Biol. 31, 395\u2013404 (2004).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"55191_CR38","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1161\/01.RES.0000209968.66606.10","volume":"98","author":"RJ Bodnar","year":"2006","unstructured":"Bodnar, R. J., Yates, C. C. & Wells, A. IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain. Circ. Res. 98, 617\u2013625 (2006).","journal-title":"Circ. Res."},{"key":"55191_CR39","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.1167\/iovs.09-3910","volume":"51","author":"FM Mo","year":"2010","unstructured":"Mo, F. M., Proia, A. D., Johnson, W. H., Cyr, D. & Lashkari, K. Interferon \u03b3\u2013inducible protein-10 (IP-10) and eotaxin as biomarkers in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 51, 4226\u20134236 (2010).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"55191_CR40","doi-asserted-by":"publisher","first-page":"6571","DOI":"10.4049\/jimmunol.174.11.6571","volume":"174","author":"TJ Fry","year":"2005","unstructured":"Fry, T. J. & Mackall, C. L. The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J. Immunol. 174, 6571\u20136576 (2005).","journal-title":"J. Immunol."},{"key":"55191_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11492-7","volume":"7","author":"SM Yeon","year":"2017","unstructured":"Yeon, S. M. et al. IL-7 plays a critical role for the homeostasis of allergen-specific memory CD4 T cells in the lung and airways. Sci. Rep. 7, 11155 (2017).","journal-title":"Sci. Rep."},{"key":"55191_CR42","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.it.2015.04.003","volume":"36","author":"VL Perez","year":"2015","unstructured":"Perez, V. L. & Caspi, R. R. Immune mechanisms in inflammatory and degenerative eye disease. Trends Immunol. 36, 354\u2013363 (2015).","journal-title":"Trends Immunol."},{"key":"55191_CR43","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nature08151","volume":"460","author":"A Takeda","year":"2009","unstructured":"Takeda, A. et al. CCR3 is a therapeutic and diagnostic target for neovascular age-related macular degeneration. Nature 460, 225\u2013230 (2009).","journal-title":"Nature"},{"key":"55191_CR44","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0167-5699(97)01103-1","volume":"18","author":"H Tilg","year":"1997","unstructured":"Tilg, H., Dinarello, C. A. & Mier, J. W. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol. Today 18, 428\u2013432 (1997).","journal-title":"Immunol. Today"},{"key":"55191_CR45","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0165-2478(93)90078-G","volume":"35","author":"C Holzinger","year":"1993","unstructured":"Holzinger, C. et al. Effects of interleukin-1,-2,-4,-6, interferon-gamma and granulocyte\/macrophage colony stimulating factor on human vascular endothelial cells. Immunol. Lett. 35, 109\u2013117 (1993).","journal-title":"Immunol. Lett."},{"key":"55191_CR46","doi-asserted-by":"publisher","first-page":"e381","DOI":"10.1111\/j.1755-3768.2012.02414.x","volume":"90","author":"JB Jonas","year":"2012","unstructured":"Jonas, J. B., Tao, Y., Neumaier, M. & Findeisen, P. Cytokine concentration in aqueous humour of eyes with exudative age-related macular degeneration. Acta Ophthalmol. (Copenh) 90, e381\u2013e388 (2012).","journal-title":"Acta Ophthalmol. (Copenh)"},{"key":"55191_CR47","doi-asserted-by":"publisher","first-page":"4144","DOI":"10.1167\/iovs.16-19772","volume":"57","author":"S Rezar-Dreindl","year":"2016","unstructured":"Rezar-Dreindl, S. et al. The Intraocular Cytokine Profile and Therapeutic Response in Persistent Neovascular Age-Related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 57, 4144\u20134150 (2016).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"55191_CR48","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/jir.2008.0027","volume":"29","author":"SL Deshmane","year":"2009","unstructured":"Deshmane, S. L., Kremlev, S., Amini, S. & Sawaya, B. E. Monocyte chemoattractant protein-1 (MCP-1): an overview. J. Interferon Cytokine Res. 29, 313\u2013326 (2009).","journal-title":"J. Interferon Cytokine Res."},{"key":"55191_CR49","unstructured":"Kumar, K. P., Nicholls, A. J. & Wong, C. H. Partners in crime: neutrophils and monocytes\/macrophages in inflammation and disease. Cell Tissue Res. 1\u201315 (2018)."},{"key":"55191_CR50","doi-asserted-by":"publisher","first-page":"7802","DOI":"10.4049\/jimmunol.177.11.7802","volume":"177","author":"WK Chiu","year":"2006","unstructured":"Chiu, W. K., Fann, M. & Weng, N. P. Generation and growth of CD28nullCD8+ memory T cells mediated by IL-15 and its induced cytokines. J. Immunol. 177, 7802\u20137810 (2006).","journal-title":"J. Immunol."},{"key":"55191_CR51","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1471-2172-11-30","volume":"11","author":"S Seidler","year":"2010","unstructured":"Seidler, S., Zimmermann, H. W., Bartneck, M., Trautwein, C. & Tacke, F. Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults. BMC Immunol. 11, 30 (2010).","journal-title":"BMC Immunol."},{"key":"55191_CR52","first-page":"1111","volume":"60","author":"DG Duda","year":"2000","unstructured":"Duda, D. G. et al. Direct in vitro evidence and in vivo analysis of the antiangiogenesis effects of interleukin 12. Cancer Res. 60, 1111\u20131116 (2000).","journal-title":"Cancer Res."},{"key":"55191_CR53","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.4049\/jimmunol.152.5.2172","volume":"152","author":"AJ McKnight","year":"1994","unstructured":"McKnight, A. J., Zimmer, G. J., Fogelman, I., Wolf, S. F. & Abbas, A. K. Effects of IL-12 on helper T cell-dependent immune responses in vivo. J. Immunol. 152, 2172\u20132179 (1994).","journal-title":"J. Immunol."},{"key":"55191_CR54","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1146\/annurev.iy.13.040195.001343","volume":"13","author":"G Trinchieri","year":"1995","unstructured":"Trinchieri, G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13, 251\u2013276 (1995).","journal-title":"Annu. Rev. Immunol."},{"key":"55191_CR55","doi-asserted-by":"crossref","unstructured":"Benson, J. M. et al. Therapeutic targeting of the IL-12\/23 pathways: generation and characterization of ustekinumab. Nat. Biotechnol. 29 (2011).","DOI":"10.1038\/nbt.1903"},{"key":"55191_CR56","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/jnci\/87.8.581","volume":"87","author":"EE Voest","year":"1995","unstructured":"Voest, E. E. et al. Inhibition of angiogenesis in vivo by interleukin 12. J. Natl. Cancer Inst. 87, 581\u2013586 (1995).","journal-title":"J. Natl. Cancer Inst."},{"key":"55191_CR57","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1167\/iovs.13-13248","volume":"55","author":"T Ristau","year":"2014","unstructured":"Ristau, T. et al. Allergy is a protective factor against age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 55, 210\u2013214 (2014).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"55191_CR58","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1182\/blood-2004-08-3178","volume":"105","author":"KH Hong","year":"2005","unstructured":"Hong, K. H., Ryu, J. & Han, K. H. Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A. Blood 105, 1405\u20131407 (2005).","journal-title":"Blood"},{"key":"55191_CR59","doi-asserted-by":"crossref","unstructured":"Sadda, S. R., Tuomi, L. L., Ding, B., Fung, A. E. & Hopkins, J. J. Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration. Ophthalmology 125 (2018).","DOI":"10.1016\/j.ophtha.2017.12.026"},{"key":"55191_CR60","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1001\/archopht.121.5.667","volume":"121","author":"MC Gillies","year":"2003","unstructured":"Gillies, M. C. et al. A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results. Arch. Ophthalmol. 121, 667\u2013673 (2003).","journal-title":"Arch. Ophthalmol."},{"key":"55191_CR61","doi-asserted-by":"crossref","unstructured":"Kurup, S. K., Gee, C. & Greven, C. M. Intravitreal methotrexate in therapeutically resistant exudative age-related macular degeneration. Acta Ophthalmol. (Copenh) 88 (2010).","DOI":"10.1111\/j.1755-3768.2009.01560.x"},{"key":"55191_CR62","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ajo.2004.09.058","volume":"139","author":"NN Markomichelakis","year":"2005","unstructured":"Markomichelakis, N. N., Theodossiadis, P. G. & Sfikakis, P. P. Regression of neovascular age-related macular degeneration following infliximab therapy. Am. J. Ophthalmol. 139, 537\u2013540 (2005).","journal-title":"Am. J. Ophthalmol."},{"key":"55191_CR63","doi-asserted-by":"crossref","unstructured":"Theodossiadis, P. G., Liarakos, V. S., Sfikakis, P. P., Vergados, I. A. & Theodossiadis, G. P. Intravitreal administration of the anti-tumor necrosis factor agent infliximab for neovascular age-related macular degeneration. Am. J. Ophthalmol. 147 (2009).","DOI":"10.1016\/j.ajo.2008.12.004"},{"key":"55191_CR64","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","volume":"112","author":"J Cohen","year":"1992","unstructured":"Cohen, J. A power primer. Psychol. Bull. 112, 155\u2013159 (1992).","journal-title":"Psychol. Bull."},{"key":"55191_CR65","doi-asserted-by":"publisher","first-page":"511","DOI":"10.2147\/OPTH.S95956","volume":"10","author":"A Pokharel","year":"2016","unstructured":"Pokharel, A., Shrestha, G. S. & Shrestha, J. B. Macular thickness and macular volume measurements using spectral domain optical coherence tomography in normal Nepalese eyes. Clin Ophthalmol. 10, 511\u2013519 (2016).","journal-title":"Clin Ophthalmol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55191-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55191-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55191-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T06:24:54Z","timestamp":1695536694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55191-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,19]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["55191"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-55191-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,19]]},"assertion":[{"value":"23 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19447"}}